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ABSTRACT 
 
Due to the contribution of hypertension to various cardiovascular diseases, many studies are 
currently focused on identifying efficient bioactive compounds with antihypertensive activity 
and thus reducing the levels of cardiovascular disease. ACE inhibitors are an important 
component of the therapeutic regimen for treating hypertension, but due to the increase in the 
prevalence of side effects of synthetic compounds, alternative and complementary medicines 
which may consist of pure bioactive compound or a combination of various compounds from 
natural sources are gaining importance in overcoming hypertension. Hypericum perforatum 
has been studied for various activities including anti-bacterial, anti-depressant, anti-oxidant 
properties, but studies on its cardiovascular effects specifically ACE inhibitory activity have 
not yet been explored. In this study, ACEI assay-guided fractionation of the ethanol extract of 
Hypericum perforatum was carried out other to isolate a compound with ACE inhibition. A 
compound – (3-hydroxy 4, 4 dimethyl-4-butyrolactone) was isolated from an active fraction of 
the plant extract and  was tested for ACE inhibition and its chemical structure elucidated  using 
1HNMR and C13NMR spectrometry and further characterized using mass spectrometry and 
FTIR. 
The pure compound: 3-hydroxy 4, 4 dimethyl-4-butyrolactone eluted from ethyl acetate: 
hexane solvent ratio (80:20) with a molecular formula of C6H10O3 and molecular mass of 130. 
The ACE inhibitory activity of the active compound was compared to that of the standard ACEI 
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drug, captopril, with 1 mg/ml of the compound inhibiting ACE by 70% compared to 98.58% 
with captopril.  IC50 was calculated as 63.88 µg/ml for the active compound compared to 
0.0165 µg/ml for captopril. 
 
3-hydroxy 4, 4 dimethyl-4-butyrolactone may be wholly or partly responsible for the ACE 
inhibitory activity of Hypericum perforatum, and has promise as a lead compound for 
development of ACEI for the treatment of cardiovascular disease.  
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 CHAPTER 1 
INTRODUCTION 
 
1.1 Epidemiology of cardiovascular disease 
 
The epidemiological transition was first explained by Abdel Omran in the 1970s as a change 
in predominant forms of disease and mortality that affects a population negatively as its 
economy and health system develops (Omran, 1970). Chronic diseases are now the main 
dominant cause of the global burden of disease, and cardiovascular disease (CVD) is the largest 
contributor to chronic diseases. An estimated 29.6% of all deaths were caused by CVD in 2010 
of which Ischaemic heart disease alone accounted for 7 million deaths worldwide (Wong, 
2014). In 2013 the Global Burden of Disease Study estimated that almost 30% of all deaths 
worldwide were caused by CVD (Wong, 2014). 
 
The rate of CVD deaths are decreasing in most high-income countries but increasing in most 
low and middle-income countries (Bhatnagar et al., 2015). CVDs consists of chronic heart 
diseases (CHD) including: stable, unstable and non-fatal myocardial infarction (MI), coronary 
death, heart failure, cardiac arrest, ventricular arrhythmias, sudden cardiac death, rheumatic 
heart disease, transient ischaemic attack, ischaemic stroke, subarachnoid, intra-cerebral 
haemorrhage, abdominal aortic aneurysm, peripheral artery disease, and congenital heart 
http://etd.uwc.ac.za/
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disease (Wong, 2014). Ischaemic heart disease is the biggest manifestation of CVD followed 
by cerebrovascular disease causing the second highest mortality rate (Valentin Fuster, 2010). 
 
 According to the WHO, cardiovascular disease is today the main cause of global mortality, 
with expected increases in the mortality rate in the future (WHO, 2008).  The number of CVD 
deaths mostly from stroke, heart disease, and rheumatic heart disease increased from 14.4 
million in 1990 to 17, 5 million in 2005, and most of these deaths occurred in low and middle-
income countries. Researchers believe that by 2030 non-communicable diseases will be 
responsible for three-quarters of deaths worldwide of which CVD will be responsible for more 
deaths in low-income countries than infectious disease, maternal, perinatal conditions and 
nutritional disorders combined (Valentin Fuster, 2010). 
In South Africa, about 6.3 million people are hypertensive, and with poor blood pressure 
control (Valentin Fuster, 2010). The National Demographic Health Survey found that of all 
individuals living with hypertension only 39% of cases were documented and less than a third 
(29%) of the hypertensive patients were diagnosed and are on medication, whilst only 14% was 
well controlled (Wright, 2007). In South Africa, the standard care for hypertension is 
prescription medication, alongside a stepwise lifestyle modification programme. There are 
several classes of drugs that have been used in the treatment of hypertension, and these include 
diuretics, beta-blockers (β-blockers), calcium channel blockers (CCB‘s) and angiotensin-
converting enzyme (ACE) inhibitors (Wright, 2007) 
http://etd.uwc.ac.za/
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The proportion of all deaths caused by CVD is greater in women (51%) than men (42%) as 
compared to 19% and 23% respectively for cancer. Coronary heart disease (CHD), when 
considered separately, accounts for 1.8 million deaths on an annual basis. CHD causes one in 
five of all deaths in patients suffering from CVD ( Nichols et al, 2014; Wong, 2014). The risk 
factors such as hypertension, smoking, diabetes mellitus, high cholesterol levels and obesity 
are the top six causes of death globally (Wong, 2014). Prevention of CHD focuses on 
identifying and managing these risk factors at both the population and individual levels through 
primordial, primary, and secondary prevention (Wong, 2014). Minimizing obesity, sedentary 
lifestyle and an unhealthy diet can reduce the incidence of heart disease, stroke, and diabetes 
mellitus by 80% (Valentin Fuster, 2010). 
 
Recent epidemiological studies have provided valuable insights into the natural history and risk 
factors associated with the development and prognosis of CVD. These provide the foundation 
for intervention studies as well as clinical trials that are aimed at the primordial, primary and 
secondary prevention of CVD (Wong, 2014). Primordial prevention is mainly focused at 
preventing CVD risk factors such as hypertension, obesity, and dyslipidemia, whereas primary 
prevention focuses on the modification of these factors and the prevention of clinical 
manifestations of CVD such as myocardial infarction and stroke. Secondary prevention is 
http://etd.uwc.ac.za/
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aimed at patients who have already have the manifestation of CVD but where extensive control 
of risk factors will have a major effect on preventing the relapse of the disease (Wong, 2014). 
 
1.2 Traditional medicines as drugs for the treatment of diseases 
 
Traditional medicine is the sum total of knowledge, skills, and practices that are based on 
theories, beliefs, and experiences which are unique to different cultures. These beliefs and 
knowledge are used to maintain health, as well as to prevent, diagnose, improve or treat 
physical and mental illnesses (Mahomoodally, 2013). Complementary or alternative medicines 
are traditional medicines that has been adopted by other populations. The extensive use of 
traditional medicines mainly in Africa has been linked to cultural and economic reasons. 
Hence, African leaders have been encouraged to promote and integrate traditional medicine 
with their health systems (Li et al., 2005). Knowledge about medicines which has been passed 
down by oral tradition from one generation to the next by an elderly priest, witch doctors or 
medicine men as written records are almost none existent (Nakamura et al., 2005). 
 
Medicines derived from plants occupy a vital place in disease treatment worldwide with their 
greatest attribute being their tendency to cause low side effects as compared to modern 
synthetic chemotherapeutic, immunomodulation and cytotoxic medicines (Ingle et al., 2017). 
According to the WHO, due to poverty and lack of access to medical care, about 65% to 85% 
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of the world population living in developing countries depend mainly on medicinal plants as 
source of primary health care. The utilization of herbal medicinal preparations are very popular 
in developing countries as they have a long-lasting tradition for their use (Calixto J.B, 2000). 
 
One of the weaknesses of herbal preparations is the fact that they do not have an immediate or 
strong pharmacological action and for this reason, they cannot be used for emergency 
treatments. Herbal medicines are generally associated with the widely believed myth that they 
are very safe and free from side effects, but the presence of many toxic constituents such as 
digitalis, pyrrolizidine alkaloids, ephedrine, and phorbol esters proves otherwise (Calixto J.B, 
2000). Herbal plants do however have less frequent adverse effects as compared to synthetic 
drugs. Two kinds of side effects for herbal medicines have been identified. The first kind of 
adverse effects are intrinsic to herbal drugs, meaning they are mainly linked to the predictable 
toxicity, overdose and contra-interaction with other conventional drugs. The second kind of 
adverse effects are extrinsic to the preparation which is related to several manufacturing 
problems like the miss-identification of the plant, lack of standardization, poor good 
manufacturing practice, contamination, substitution, adulteration, and incorrect preparation 
and dosage (Calixto J.B, 2000).  Over the years there has been a lot of success with herbal 
medicines as over 4000 herbal medicines since 1978 have been submitted to 
pharmacovigilance in Germany and many have been withdrawn from the market because of 
their toxic effect and risk for human use (Calixto J.B, 2000). 
http://etd.uwc.ac.za/
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1.3 Medicinal plants as the source of drug 
 
Herbal medicine is based on the principle that plants contain natural substances that can 
promote health and alleviate illness. Recent researches have focused their interest on herbal 
plants possessing various medicinal properties.  A wide variety of phytochemicals like 
flavonoids, terpenoids, lignans, sulfides, polyphenolics, carotenoids, ceramics, saponins, plant 
sterols, curcumins, and phthalides has been identified and extracted from many herbal plants. 
Many western drugs have their origins in plant extracts including ephedrine which was 
extracted from the Chinese plant Ephedra and used for asthma treatment, salicylic acid was 
obtained from a willow tree bark and was used to relieve fevers, and Paclitaxel was isolated 
from the bark of Pacific yew and used for cancer treatment (Craig, 1999). Natural products are 
widely sold over the counter for their use in the treatment and management of common ailments 
and conditions such as arthritis, anxiety, cough, cold, constipation, fever, headaches, stress, 
ulcers, weakness and pre-menstrual syndrome. Some of the common herbs used today are 
Echinacea, garlic, ginseng, gold-ensal, gingko, saw palmetto, aloe vera, and feverfew. 
Researchers have proven the usefulness of ginger for motion sickness, licorice (glycyrrhizin) 
for ulcers, and Echinacea for immune support (Craig, 1999).  
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1.4 Medicinal plants used in CVD 
 
 Natural medicines with cardiovascular properties have been used to manage and treat people 
with congestive heart failure, systolic hypertension, angina pectoris, atherosclerosis, cerebral 
insufficiency, venous insufficiency, and arrhythmias (Mashour and George, 2015). Some of 
these natural medicines with known cardiovascular effects include: digitoxin which was 
extracted from D. pupurea or D. lanata and digoxin which was extracted from D. lanata alone. 
Adonis, black Indian hemp, red-headed cotton hemp, balloon cotton, king’s crown, 
wintersweet, sea mango, wall-flower, lily of  the  alley, rubber vine, black hellebore, oleander, 
frangipani, strophanthus, yellow oleander, and squill all contain potent cardio-active glycosides 
which have a positive inotropic action on the heart for the treatment of congestive heart failure 
(Mashour and George, 2015). The roots of R. serpentina (snakeroot) and its alkaloid- reserpine 
lowers blood pressure by decreasing cardiac output, peripheral vascular resistance, heart rate 
and renin secretion. Stephania tetrandra has been shown to have a calcium channel blocking 
effect. The root of Lingusticum wallichii, Evodia rutaecarpa, Uncaria rhynchophylla are all 
Chinese plant used as either circulatory stimulant, hypertensive, hypotensive drug or sedative. 
The seeds of horse chestnut, Aesculus hippocastanum have long been used to treat venous 
disorder like varicose veins as they inhibit the activity of lysosomal enzymes thought to 
contribute to the varicose vein by weakening vessel walls and increasing permeability which 
causes dilated veins and edema. (Mashour and George, 2015). 
 
http://etd.uwc.ac.za/
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1.5 Modern drug therapy  
 
The variety and use of cardiovascular drugs have greatly increased over the past decades, 
starting from the 1950s when an effective oral diuretic became available, to the 1960s when a 
class of beta blockers was discovered, all through to the 1980s when calcium channel blockers 
and angiotensin converting enzymes inhibitors became widely used. All these drug discoveries 
made it possible to dramatically change the treatment of heart failure and hypertension and 
brought about major changes in the doctors’ ability to treat patients with hypertension or angina 
pectoris, as well as allowing patients with hypertension, heart failure, and coronary artery 
disease to be treated more effectively (Weisfeldt and Zieman, 2007). The development and use 
of thrombolytics have revolutionized the ability to treat patients with heart attacks. There are 
many other different classes of drugs used for various cardiovascular diseases. These drug 
classes include: Statins, antihypertensive, antiarrhythmic, diuretics, anticoagulants, antiplatelet 
and thrombolytics (Weisfeldt and Zieman, 2007). 
 
 The efficacy of these treatments to reduce cardiovascular morbidity and mortality in stroke, 
heart attack, and heart failure was established principally through large-scale clinical trials. 
These large scale clinical trials may also include studying phytochemicals of various herbal 
extracts in order to determine their biological activity. Phytochemicals found in variety of 
herbal extracts have shown to reduce high blood pressure, cholesterol concentrations, provide 
some protection against cancer, and stimulate the immune system. Therefore the need for new 
http://etd.uwc.ac.za/
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drugs from these phytochemical that will be more affordable, more available and safe is 
increasing (Weisfeldt and Zieman, 2007). 
 
There is on-going research to prove the pharmacological actions of many of these cardio-
protective herbal medicines and to encourage the future pharmaceutical development of many 
of these herbal drugs that could be therapeutically beneficial. Studies on cardiovascular effects 
of Hypericum perforatum have not yet been documented but its phytochemical profile has been 
reported. This study will determine the ACE inhibitory effect of compound(s) isolated from 
Hypericum perforatum. 
 
1.6 Aims  
 
The aim of this study is to isolate a biologically active compound from Hypericum perforatum 
that has ACE inhibitory activity using the bioassay-guided fractionation method. The study 
will also aim to characterize the isolated compound(s) using NMR, MS and IR spectroscopy. 
 
1.7 Objectives 
 
The objectives of this is study include: 
http://etd.uwc.ac.za/
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 To determine the ACE inhibitory activity of fractions of the organic extracts of 
Hypericum perforatum leaves.  
 To isolate compound(s) with ACE inhibitory activity from the ACE inhibitory-active 
fraction(s) of the extracts of Hypericum perforatum leaves.    
 Characterisation of the isolated active compound(s) using NMR and IR spectroscopy, 
and high-resolution mass spectrometry.  
 
 
1.8 Hypothesis 
 
To guide this research the following hypothesis was formulated: 
Hypericum perforatum contains compound(s) with potent ACE inhibitor activity comparable 
to that of captopril.  
 
  1.9 Research question  
 
This research was designed in other to answer this question below: 
Does Hypericum perforatum contain compound(s) with ACE inhibitory effect? 
 
 
http://etd.uwc.ac.za/
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1.10 Justification of study  
 
Investigating the ACE-inhibitory activity of Hypericum perforatum will further contribute to 
studies towards alleviating hypertension in SA. At the end of this study, the isolated compound 
thus represents a new lead compound for the possible development of a new ACE inhibitors. 
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CHAPTER 2. 
 
LITERATURE REVIEW 
 
INTRODUCTION 
2.1 Botanical profile of Hypericum perforatum 
 
The genus hypericum Linn belongs to the family hypericaceae, comprising of about 450 
species with Hypericum perforatum being the most representative. Hypericum perforatum L. 
(hypericaceae), is a low evergreen shrub with attractive bright orange-yellow flowers. It 
produces a slender, erect stem up to 1m high in summer and spreading prostrate stems in winter, 
with heights up to 60cm. It has light green leaves with translucent oil glands and bright yellow 
star flowers with black oil glands on the margin of the petals from October to January. The 
seeds are small, elongated and with rounded ends. They germinate after some days if exposed 
to soil at high temperatures. The brownish yellow roots have a woody and resistant consistency 
from the seedling. Hypericum perforatum is a herbaceous perennial herb which is indigenous 
to North America, Europe, the Canary Island and western Asia. Common names for Hypericum 
`perforatum include St John’s Wort, goat weed, touch and heal, penny-john, Klamath weed, 
gammock and rosin rose  (Kopleman et al., 2001; Ganzera, Zhao and Khan, 2002).  The name 
“hypericum” is derived from Greek with hyper meaning over and eikon meaning image and 
http://etd.uwc.ac.za/
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the name St John’s Wort was given as the flowers bloom around Saint John’s day, 24th of June 
(Barnes, Anderson and Phillipson, 2001). 
 
Traditionally St John’s Wort has been used for the treatment of excitability, neuralgia, sciatica, 
menopause neurosis, anxiety, depression, malaria, viral infections, bacterial infections, burns, 
wounds, insect bites, as an astringent, stress reduction, immune support and as a nerve tonic 
(Choudhuri and Valerio, 2005). The plant has also been indicated for gout, hepatic disorders 
and gastric ulcers. Today it is commercially available in tablet, capsule, tea, and tincture form 
for the treatment of mild to moderate depression (Bilia et al., 2001).  
 
Hypericum perforatum contains at least ten biologically active compounds belonging to 
various phytochemical classes including: Flavonoids (rutin, hyperoside, isoquercitrin, 
quercitrin, and quercetin); naphthodianthrones (hypericin, pseudohypericin) and 
phloroglucinols (hyperforin and adhyperforin); and to some lesser extent phenylpropanes, 
flavonol derivatives, flavones, proanthocyanidins, xanthones, some amino acids, and essential 
oils ((Tatsis et al., 2007). The qualitative and quantitative variation of secondary metabolites 
in Hypericum perforatum is affected by the ecological, environmental, physiological and 
genetic factors. When the plant extract is exposed to light, protohypericin and 
protopseudohypericin are converted into hypericin and pseudohypericin respectively and this 
http://etd.uwc.ac.za/
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also leads to the degradation of phloroglucinol which is very sensitive to oxidation and is 
unstable in solution when exposed to air (Tatsis et al., 2007). 
 
This chapter presents a review of Hypericum perforatum; phytochemical constituents and 
pharmacological and clinical studies done on the plant. The use of bioassays to identify 
bioactive compounds in the plants as well as an overview of the actions of angiotensin 
converting enzyme and angiotensin converting enzyme inhibitors will also be covered.   
 
2.2 Phytochemical profile  
 
2.2.1 Naphthodianthrones  
 
These compounds mainly attracted biochemists at first because of their intense red colour and 
their phototoxic properties. Total hypericin content is used to standardize St John's wort with 
the total content varying from 0.05% to 3%(Choudhuri and Valerio, 2005). Initially, two photo-
derivatives namely protohypericin and pseudoprotohypericin were isolated from the plant but 
they proved to be unstable, but were later converted to their stable form, hypericin and 
pseudohypericin due to the effect of light. Pseudohypericin is the main naphthodianthrone in 
St John’s Wort and is mainly present in two to four folds higher than hypericin (Patočka, 2003). 
These phytochemicals have a selective solubility in almost all solvents but they are insoluble 
in water at ambient temperature, although their solubility increases at higher temperatures. 
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Hypericin is documented to be the main photosensitizing constituent of Hypericum perforatum 
and is believed to cause hypericism.  It is used in photodynamic cancer therapy as a 
photosensitizer whereas, pseudohypericin has no photo toxicity (Patočka, 2003). 
 
Clinical data has suggested that the antiretroviral effect of hypericin and pseudohypericin can 
be due to the inhibition of some phosphorylation influenced by protein kinase C during the 
cell’s viral infection (Patočka, 2003). Further findings indicate that hypericin inhibits the DNA 
relaxation activity of topoisomerase II alpha. This antagonism is thought to be due to 
hypericin’s ability to distort DNA structure, therefore, preventing topoisomerase II binding or 
DNA cleavage.(Patočka, 2003).  
 
Hypericin is thought to be derived from anthranoid metabolism and emodinanthrone is thought 
to be the precursor. The protonaphthodianthrones, protohypericin, and protopseudohypericin 
represent partially cyclic precursors of the naphthodianthrones, which upon irradiation with 
visible light, is converted into their naphthodianthrone analogs. The ratio of 
protonaphthodianthrones to naphthodianthrones in the fresh plant and in the extract may vary 
significantly between 1:5 and 5:1 respectively, depending on the extent of the photo-conversion 
that took place during the preparation of the extract. Cyclopseudohypericin is thought to be an 
oxidation product of pseudohypericin (Wild, 2003). 
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 Hypericin and its analogs are slightly acidic compounds. They are freely soluble in methanol 
as well as pyridine and other organic bases, yielding cherry red solutions with red fluorescence. 
Pseudohypericin and hypericin both absorb visible light with a maximum absorption at 588nm. 
They are highly fluorescent in methanol when exposed to ultraviolet (UV) light. Hypericin and 
pseudohypericin are soluble in alkaline solutions, with the solutions red below pH 11.5, and 
green with red fluorescence above pH 11.5. The naphthodianthrones, especially hypericin are 
almost insoluble in water at ambient temperature. However, it has been found that more than 
40% of hypericin and psuedohypericin present in the herb is extractable when using water 
heated between 60oC and 80oC. Hypericin forms monobasic salts with inorganic bases between 
a pH of 4 and 11 and are soluble in polar solvents. However, pseudohypercin and hypericin 
occur mainly as potassium salts (Wild, 2003). 
 
2.2.2 Phloroglucinols 
 
Two phloroglucinol compounds have been found in Hypericum perforatum namely hyperforin 
as the main compound and adhyperforin containing one additional methyl group. Both 
compounds occur in the reproductive part of the plant and to a lesser extent in flowers and 
greater extent in ripe fruit. Hyperforin is lipophilic and unstable towards light and heat.  
Although the pharmacological activities of hyperforin are little known, it has been shown to 
inhibit or modulate various neurotransmitter systems in vitro as it is a potent reuptake inhibitor 
of serotonin, dopamine, noradrenaline, and GABA (Patočka, 2003). It has been demonstrated 
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as a modulator of various neuronal ion channels as well as the inhibition of smooth muscle 
contraction induced by many neurotransmitters. It is believed that hyperforin is the major active 
phytochemical responsible for the antidepressant effects of the plant, with its mechanism of 
action considered to be due to synaptic reuptake of neurotransmitters (Patočka, 2003). It has 
been reported that the amount of both compounds increases from about 2% hyperforin and 
0.2% adhyperforin in the unripe fruits to 5% hyperforin and 2% adhyperforin in the ripe fruits. 
Hyperforin and adhyperforin are acylphloroglucinol-type compounds, which consist of a 
phloroglucinol skeleton substituted with lipophilic isoprene chains. The phloroglucinols are 
lipophilic, unstable towards heat and light either in storage or in solution, and are very 
susceptible to oxidation (Wild, 2003). The stability of isolated hyperforin in solution and solid 
form was investigated in several antioxidant systems, and hyperforin was reported to show 
greater stability in polar solvents than in non-polar solvents. It was shown to be much more 
stable in a pH 2.0 methanol solution than in a pH 12 solution. It was also reported that 
degradation under light exposure can be diminished in methanol by acidification at a pH of 2.0, 
and degradation under light exposure at pH 12.0 results in total decomposition within 30 days. 
However, when kept in the dark, hyperforin is stable in acid and alkaline methanolic solutions 
(Wild, 2003). 
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2.2.3. Flavonoids 
 
This group of compounds includes the flavonol, the flavonol glycosides, and the flavones. 
Flavonols are the aglycone forms of the flavonol glycosides and include quercetin, kaempferol, 
luteolin, and myricetin. Of these four, quercetin is by far the most common (Wild, 2003). 
Quercetin is the major biologically active compound of Hypericum perforatum constituting 
between 2% to 4%. Hyperin and rutin mainly dominate among the glycosides followed by 
quercitrin then isoquercitrin. These flavonoid glycosides have spasmolytic activity and are 
inhibitors of monoamine oxidase A and catechol-O-methyltransferase enzymes, but the levels 
of the flavonoids are too low to be responsible for the therapeutic efficacy of the crude drug. 
The flavonoids are also believed to be capillary protectants. (Patočka, 2003). 
 
2.2.4 Proanthocyanidins 
 
These are present in the plant in the form of tannins and they are measured by their conversion 
to red colour cyanidins with their concentration highest at the pre-flowering stage. They also 
possess biological effect including antioxidant, antiviral and antimicrobial effects (Patočka, 
2003). Phenylpropanoids, mainly present as esters of hydroxycinnamic acid and chlorogenic 
acid have been detected, but at concentrations below 1%.  Phenylpropanoids have been 
reported to have central stimulating activity. Caffeoylquinic acid, a chlorogenic acid has been 
shown to exhibit weak spasmolytic activity in vitro and choleretic activity in vivo (Nahrstedt 
and Butterweck, 2013). 
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2.3 Pharmacological activities of H. perforatum  
 
The plant has been assessed pharmacologically for a broad spectrum of effects that  include: 
anti-anxiety, antibiotic, anti-spasmodic, anti-oxidant, calcium channel blocker, gene 
expression induction, wound healing, smooth muscle relaxant, sleep potentiator, anti-
inflammatory and anti-microbial activity. 
 
The essential oils in the plant have been reported to possess anti-microbial activity, with the 
essential oils and water-soluble part of the alcoholic extracts showing minor anti-fungal and 
significant antibacterial properties. Hyperforin and adhyperforin has been reported to have an 
antibiotic effect three times greater than that of sulphanilamide through keloid inhibition (Singh 
et al., 1999). 
 
Hypericin has shown significant antidepressant activity by inhibiting monoamine oxidase 
(MAO) and β-hydroxylase enzymes in vitro.  Hypericin also plays a role in the suppression of 
interleukin-6 in the blood and also modulates the expression of serotonin receptors that inhibit 
the neuronal uptake of serotonin, norepinephrine, and dopamine. Hypericin, hyperforin, and 
xanthones are the main constituents that exhibit the antidepressant activity ((Vattikuti and 
Ciddi, 2005). 
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Hypericin was found to be active against human leukaemia, squamous carcinoma, 
nasopharyngeal carcinoma, mouse mammary carcinoma, and fibroblast cells. It also inhibits 
the Epidermal Growth Factor (EGF) receptor and Protein Tyrosine Kinase (PTK) activity. 
Hyperforin inhibits MT-450 breast carcinoma in immune-competent Wistar rats to a similar 
extent as that of paclitaxel without any sign of acute toxicity (Vattikuti and Ciddi, 2005). 
Hypericin is well-known as a photosensitizing agent for photodynamic therapy of cancer and 
viral infections. The antiviral activity of Hypericin and pseudohypericin against retrovirus like 
HIV involves the combination of its photodynamic and lipophilic properties while hypericin 
alone binds the cell membrane and cross-links the viral protein leading to its inability to retrieve 
the reverse transcriptase activity (Singh et al., 1999).  Also, activity has been reported against 
murine cytomegalovirus, sindbis virus and equine infectious anaemia virus (Singh et al., 1999).  
The mechanism of action of this activity seems to involve the photo activation process that 
forms singlet oxygen, rendering viral fusion inactive. Although it is seen that hypericin has 
some antiviral activity in vivo, the photodynamic properties do limit its usefulness as an 
antiretroviral agent. However, hypericin can photo reduce oxygen to superoxide radicals, 
forming semi-quinone in the absence of light. Both hypericin and pseudohypericin have been 
shown to inhibit regulatory enzymes, proteins kinase C as well as inhibit receptor tyrosine 
kinase activity of epidermal growth factor (Singh et al., 1999). The procyanidin fraction 
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enhances coronary flow by antagonizing histamine or prostaglandin F2α-induced arterial 
contractions (Singh et al., 1999). 
2.4 Clinical Studies on H. perforatum 
 
Hypericum perforatum has been tested clinically for anti-retroviral, antibacterial, anticancer, 
anti-mutagenic, antiviral activities and as an Immuno-stimulant, but the most documented 
clinical studies are on its anti-depressant activity. 
 
Miller and Rossel (1994) reported that St. John’s Wort extracts inhibited serotonin receptor 
expression at 50 µM (~25ug/ml), while Perovic and Miller (1995) reported inhibition of 
serotonin uptake at 6.2 µg/ml of the extracts. The Inhibition of catechol-O-methyl transferase 
(COMT) was also reported with various ethanolic St. John’s Wort fractions at supra-
physiologic concentrations of up to 500 µg/ml. St. John’s Wort extracts also reduced cytokine 
expression and were hypothesized to reduce depression in susceptible individuals by reducing 
interleukin concentrations. Although this hypothesis hasn’t been proven, the link between 
depression and the immune system is gaining greater attention (Singh et al., 1999). 
 
During a bioassay-guided fractionation of a methanolic extract of St John’s Wort, hypericin 
and pseudohypercin were detected as the compounds that showed greatest antidepressant 
activity in a forced swimming test  (Nahrstedt and Butterweck, 2013).. In a tail suspension test 
in mice, pure hyperforin reduced immobility time with 4 mg/kg and 8 mg/kg doses, but was 
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inactive below or above these dosages. In the same study, it was also shown that step by step 
removal of hyperforin and hypericin didn’t result in the loss of the whole plant pharmacological 
activity, meaning that other constituents of the plant may contribute to the antidepressant 
activity (Nahrstedt and Butterweck, 2013).. 
 
Amentoflavone was shown to cross the blood-brain barrier in vitro by passive diffusion, and in 
forced swimming tests, confirmed the antidepressant activity of flavonoids with an activity that 
was comparable to imipramine. Further evidence of the antidepressant activity of the plant’s 
flavonoids was provided by Butterweck (1997), who reported that isoquercitrin, hyperoside 
and miquelianin down-regulated plasma adrenocorticotropic and corticosterone hormone level 
after two weeks of daily treatment (Nahrstedt and Butterweck, 1997). 
 
2.5. Methods for the isolation of pure compounds with specific 
activity from medicinal plants. 
 
There are several steps to be taken before the utilization of a biologically active compound 
from herbal plant in humans, and these steps include: extraction, pharmacological screening, 
isolation, characterization of the bioactive compound, toxicological evaluation and clinical 
evaluation. 
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2.5.1 Extraction techniques  
 
Extraction is the process of separating a medicinally active agent or compound(s) from a solid 
or liquid mixture by using a suitable liquid solvent. Several methods for extracting compounds 
from a plant matrix exist and include: maceration, percolation, soxhlet extraction, decoction, 
hydro-distillation, ultrasound assisted extraction, microwave assisted extraction and 
supercritical fluid extraction.(Sasidharan et al., 2011). 
 
Maceration involves leaving the powdered plant soaked in a suitable solvent in a closed 
container at room temperature with occasional shaking. The solvent is filtered, leaving behind 
a concentrated extract. This process is inexpensive, non-complicated and limits compound 
degradation when used with cold solvents. The set back to this process is that the extraction 
takes longer and uses large amounts of solvent. Percolation extraction is similar to maceration, 
but hot solvent is continuously passed through the plant material. This process is much quicker  
but could produce decomposition because of the hot solvents used (Sharma et al ., 2015). 
Decoction process is used for extraction of compounds that are soluble in water and less heat 
sensitive. This process involves the addition of distilled water to the dried extract with 
continuous heating for a period of time at 1000C. It is cooled down to room temperature, solvent 
is filtered to obtain the filtrate. This filtrate is concentrated to obtain the extract.  The advantage 
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of this method is that it does not require expensive equipment and it is very easy to perform, 
but it cannot be used on heat sensitive constituents (Lumpur, 2017).  
 
Soxhlet extraction is a continuous form of percolation with fresh solvent until complete 
exhaustion of the solute in the raw material (Lumpur, 2017). The material is separated from 
the extract by covering it in a paper thimble underneath the dropping condensed solvent, and 
when full the solvent in the thimble goes into the main vessel containing the extractant. The 
separation of the solvent is made using rotary evaporator, whereby a vacuum evaporation is 
carried out using a vacuum pump with a check valve (Lumpur, 2017). The advantage of this 
process is that fresh solvent continually extracts the plant material more effectively with little 
solvent. This method does not require filtration after extraction. Its disadvantage is that it brings 
about most decomposition with the high temperature and continuous heating. Long duration 
and high extraction amount of solvent consumed can lead to economic loss and environmental 
problems ( Lumpur, 2017). 
 
Hydro-distillation is mainly used for the extraction of plant material that doesn’t use organic 
solvents. In this process, water is added in sufficient amount to plant materials that are packed 
in a still container and then the plant sample get heated either by boiling or by means of direct 
steam. The hot water and steam acts as an important factors to free bioactive compounds from 
plant tissue. Indirect cooling by water condenses the vapour mixture of water and oil, and this 
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mixture flows from the condenser to a separator where oil and bioactive compounds separates 
automatically from water ( Lumpur, 2017). The main drawback to this method is that the high 
temperatures can cause loss of some volatile components, hence limiting its use for heat 
sensitive compound extraction (Lumpur, 2017). 
 
Ultrasound assisted extraction is an inexpensive, fast, simple, less energy consuming and 
efficient extraction technique that produces acoustic cavitation in the solvent by the passage of 
an ultrasound wave. Ultrasound also exhibits an automated effect by allowing greater diffusion 
of solvent into the tissue and increasing the contact surface area to allow the solute to quickly 
diffuse from solid phase to the solvent ( Lumpur, 2017). Its advantages include a reduction in 
extraction time and solvents used. There is more effective mixing, faster energy transfer and 
reduced thermal gradient and extraction temperatures (Wen et al., 2019). The disadvantage is 
mainly based on the fact that this technique have lower efficiency when compared to the other 
new extraction techniques (Lumpur, 2017). 
 
Microwave assisted extraction is a method used to extract soluble products into a fluid from a 
wide range of material using a microwave (non-ionizing electromagnetic fields in the 
frequency range from 300 MHz to 300 GHz) (Wen et al., 2019). Heating with a microwave 
causes a direct impact on polar materials. Microwaves penetrate into biomaterials by 
interacting with polar molecules such as water inside the materials through generation of heat. 
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The infiltration of microwaves into plant matrix depends on factors such as: dielectric constant, 
moisture content, temperature, and the frequency of the electrical field. The water contained in 
a plant material makes it possible for the absorption of microwave energy which leads to the 
internal superheating and cell structure disruption. This action facilitates the diffusion of 
bioactive compounds from the plant matrix ( Lumpur, 2017). Microwave assisted extraction is 
less time consuming, inexpensive, with less solvent is used and has a special heating 
mechanism.  The drawback to this technique is that the operating temperature is high which 
causes problems for the extraction of antioxidants. This process also produces low yields when 
solutes or solvents are non-polar and it also needs a filtration or centrifugation stage to remove 
residue of the extract (Lumpur, 2017). 
 
Supercritical fluid extraction is the process of separating the extractant from the medium using 
supercritical fluids such as carbon dioxide (CO2) as the extracting solvent. This process mostly 
use carbon dioxide at high pressure to extract the high value products from natural materials. 
Unlike other processes, the extraction process leaves no solvent residue behind.  The CO2 is 
non-toxic, non-flammable, odourless, tasteless, inert, and inexpensive. Due to its low critical 
temperature  of 31°C, carbon dioxide is known to be perfectly adapted in food, aromas, 
essential oils and nutraceutical companies (Sapkale et al., 2010). The major disadvantage is 
mostly on the economic aspect as this method is considered more expensive than traditional 
extraction process. The technology requires a non-negligible energy consumption to establish 
http://etd.uwc.ac.za/
27 
 
the pressure and temperature during the different extraction, separation, solvent recycling 
stages (Lumpur, 2017). 
 
2.5.2 Identification and characterization methods  
 
Chromatographic techniques  
Column chromatography is an important separation technique that has a huge impact in the 
field of separation science. In Chromatography, separation depends on the compound 
distributing between the stationary and mobile phase. Stationary phases may include an 
adsorbent, a paper, or a thin layer of adsorbent on a glass plate, and the mobile phase may 
include a liquid or a gas. When the solid stationary phase is in the form of a column, this is 
known as column chromatography (Sjögren, 2005). A column is the most useful method for 
separating and purifying both liquid and solids and the principle of chromatography is based 
on the adsorption of substance by the adsorbent. The most common adsorbents used are silica, 
alumina, calcium carbonate, calcium phosphate, magnesia and starch and the selection of 
solvent is based on the nature of both solvent and adsorbent. The column chromatography will 
allow the separation and collection of compounds individually. The main disadvantage of this 
technique is that it is tedious, time consuming and complicated when it comes to larger samples 
(Weller, 2012). 
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Thin layer chromatography (TLC) and bio-autographic techniques, are quick and inexpensive 
techniques that give fast answers as to the number of components that are in a mixture. Bio-
autography technique is used specifically for determination of antimicrobial bioactive 
compound. Identification tests include spraying of phytochemical screening reagents which 
will cause colour change according to the phytochemical pre-existing in the plant extract or by 
viewing the plate under UV light as this confirms the purity and identity of the isolated 
compound (Sasidharan et al., 2011). The major advantage is that it provides light images and 
fluorescence images, and it also gives different levels of profile and corresponding integral data 
with chromatography screening and digital processing. The main disadvantage is that is has, 
low resolution, low sensitivity and difficulty detecting trace components.( Lumpur et al., 2017). 
 
High-performance liquid chromatography (HPLC) is very versatile, robust and widely used. 
This is the technique of choice for fingerprint study in the quality control of the herbal plant. 
HPLC can separate a mixture of compounds. It is used in phytochemical and analytical 
chemistry to identify, qualify and purify the individual compounds of the mixture. HPLC 
technique is based on the principal that certain compounds have different migration rates in a 
given column and mobile phase. The extent and degree of separation is determined by the 
choice of stationary phase and mobile phase (Lumpur, 2017). Purification by HPLC is a process 
whereby the target compound is separated or extracted from other compounds as each 
compound must have a distinctive peak under certain chromatographic conditions. In order to 
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get optimum separation of each compound with HPLC, a suitable detector must be selected 
and set to right detection point, separation assay must be developed, and the flow rate, a proper 
mobile phase and columns must be selected. HPLC is extremely quick and efficient method 
that is very versatile and precise when it comes to identifying and quantifying chemical 
components. Despite its advantages, HPLC can be very costly, requiring large amount of 
expensive solvents, the method can be complex to troubleshoot problems or develop new 
methods because of its range of different modules, column and mobile phase (Sasidharan et 
al., 2011). 
 
Gas chromatography (GC) is a highly sensitive powerful separation technique that is used for 
discovery of volatile organic compounds. This technique allows for more precise, quantitative 
determination of difficult mixtures, such as traces of compounds in the parts per trillions 
range(Siddiqui, 2017). The main advantage is based on its use in the study of pharmaceutical 
products with high molecular mass including polypeptides or thermally unstable antibiotics. It 
is an important tool for the analysis of impurities in pharmaceutical products. Its main 
constraint is based on its inability to detect non-volatile drug substances and it is not suitable 
for thermally liable substances (Varghese et al ., 2017). 
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Non-chromatography techniques  
Immunoassay uses monoclonal antibodies against medicines as it shows for receptor binding 
analysis, enzyme assays, quantitative and qualitative analytical techniques. Enzyme-linked 
immune-sorbent assay (ELISA) that are based on monoclonal antibodies are documented to be 
more sensitive than HPLC techniques. Major disadvantages to this technique is that results 
obtained by immunoassay needs to be confirmed using another methods such as 
chromatography coupled with mass spectrometry (Sasidharan et al., 2011). 
 
Phytochemical screening assay are a simple and inexpensive method that gives quick answers 
to the different types of phytochemicals in the mixture, it helps to give an idea regarding the 
type of phytochemical present in the extract mixture and is an important tool in the analyses of 
bioactive compounds (Sasidharan et al., 2011). 
 
2.5.3 Structural elucidation methods (spectroscopic techniques) 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) is a nuclear specific spectroscopic 
technique that uses a large magnet to analyse the intrinsic spin properties of atomic nuclei. 
NMR uses electromagnetic radiation to promote shifts between nuclear energy levels 
(Resonance). In analytical chemistry it is used in quality control and in research it is used in 
determining the content and purity of a sample as well as its molecular structure. It gives the 
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physical, chemical and biological properties of a compound (Ingle et al., 2017). One 
dimensional technique is routinely used for less complicated structures, but for more 
complicated structures of a molecule, two dimensional NMR techniques are used. 13C NMR is 
used to identify the number and types of carbon bonds that are present in a compound. 1H NMR 
is used to identify the number of hydrogen molecules that are present in the compound and also 
to identify how the hydrogen atoms are connected. (Ingle et al., 2017). The main advantage of 
NMR is its ability to rapidly screen and identify samples. The main disadvantage of this method 
is that the equipment is very costly (Ashok, 2014). 
 
Mass spectrometry (MS) is a powerful analytical technique that is known for its use in the 
identification of unknown compounds. It is also used for the quantification of known 
compounds and to elucidate structure and chemical properties of molecules. This method is 
able to determine the molecular weight of a compound (Ingle et al., 2017). MS uses a technique 
that allows small molecules to be ionized by high energy electrons. Electrostatic acceleration 
and magnetic field fluctuations accurately measures mass to charge ratios of these ions and 
therefore, provide a precise molecular weight of a compound. The disadvantage of MS is that 
it requires a pure compound and is difficult to identify volatile compounds ( Ingle et al., 2017; 
Varghese et al., 2017). Liquid chromatography coupled with mass spectrometry (LC/MS) is 
another powerful technique that is used in the analysis of complex botanical extracts. It is 
important as it provides abundant information for structural elucidation of the compounds when 
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tandem mass spectrometry (MSn) is applied. To facilitates rapid and accurate identification of 
chemical compounds in medicinal herbs, especially when a pure standard is unavailable, the 
combination of HPLC and MS are normally applied (Sasidharan et al., 2011). 
 
 
Spectrophotometry is a quantitative measurement of the reflection and transmission properties 
of a material as a function of a wavelength (Siddiqui, 2017).  Spectrophotometry is based on 
natural UV absorption and chemical reactions. The advantages of these method are low time 
and labour consumption as well as very precise when used in the analysis of pharmaceutical 
dosage form. The disadvantages of this method is that spectrometers requires frequent 
calibration to retain accuracy and precision of the instrument, therefore choosing what type of 
material to be used as calibrator requires the knowledge of the type of sample being analysed 
(Siddiqui, 2017).  
 
Ultraviolet-Visible spectroscopy uses UV-Vis light to measure the transmittance of the light 
that passes through a sample. The chemical structure of the molecule is measured as the amount 
of absorbance at any wavelength.  UV-Vis is used in a qualitative manner to identify functional 
groups or to confirm the identity of a compound by matching the absorbance spectrum. It is 
also used in a quantitative manner by determining the concentration of the compound in 
relation to its absorbance.  This is a very popular analytical technique because it is versatile 
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and is able to detect nearly every molecule. The main set back of this method is that it is  not 
sensitive enough because not a lot of light is absorbed over a short path length (Pearson et al., 
2002; Sasidharan et al., 2011).  
 
Fourier-transform infrared spectroscopy (FTIR) is a tool used for the identification of 
functional groups that are present in the unknown plant extract. It helps for the identification 
and structure determination of a molecule (Ingle et al., 2017). The FTIR of pure compounds 
are as unique as a fingerprint and for most compounds the spectrum of an unknown compound 
can be identified by comparison to a library of known compounds. This technique is very 
versatile, highly sensitive, non-invasive and non-destructive. It can be used to analyse samples 
having low transmission and weak spectra and samples can either be organic, inorganic, 
polymers or any combination of these. The disadvantage is that they often expensive, have 
lower throughput, requires more sample, labour and training as well as it being difficult to 
automate based on the fact that data can easily be manipulated (Bekele et al., 2017). 
 
Hyphenated technique is the coupling of a separation technique and on-line identification 
technique. A variety of hyphenated techniques such as LC-MS, GC-MS and LC-NMR have 
been applied in the analysis of pharmaceuticals (Saddiqe et al., 2010). The availability of 
methods permitting the analysis of the entire plant extract is a challenge because the efficacy 
of the plant of interest is not based on a single constituent but the whole mixture of constituents 
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instead(Tatsis et al., 2007). Therefore, the coupling of liquid chromatography with 
spectroscopic techniques like UV, NMR, and MS provides a useful way for quick data 
collection and structure elucidation. LC/DAD, diode array detector is effective for rapid 
screening of mixtures but the light absorbance data collection proves to be insufficient for 
structure elucidation (Tatsis et al., 2007). Hyphenated LC/UV/MS instrumentation is fast and 
it limits the exposure of samples to light and air therefore, minimizing degradation.  NMR, on 
the other hand, is a very useful technique for structural elucidation of organic molecules and 
therefore, the incorporation of LC and NMR could lead to the complete separation and structure 
determination of compounds.  LC/NMR has also become very popular and important in the 
biomedical, pharmaceutical, environmental, food, and natural food analysis as well as in drug 
metabolites identification (Tatsis et al., 2007). However one of the disadvantages of LC/NMR 
is that the amount of fraction that is eluted from the column is not sufficient to conduct further 
studies such as biological activity assays. Recent studies have documented a more hyphenated 
technique - SPE/NMR, which was used to analyse oregano plant extract. A solid phase 
extraction (SPE) unit was inserted between the LC–UV unit and NMR spectrometer so to trap 
the eluting compounds onto the SPE cartridges. Each one of the trapped compounds was eluted 
into the NMR probe with deuterated solvent (Tatsis et al., 2007). 
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For the purpose of this study, maceration, column chromatography, TLC, HPLC, NMR, MS 
and IR will be employed in the extraction, isolation, purifying and characterization of active 
compound(s) of Hypericum perforatum. 
 
 
2.7 Assays to determine cardiovascular effects of medicinal plants  
 
In the drug development process, new drug entity needs to be evaluated for its efficacy against 
the target disease. In cardiovascular disease, preclinical evaluation for efficacy would include 
in vivo and in vitro studies on the effect of the drugs on the heart, vasculature and enzymes 
involved in homeostasis. The efficacy of new pharmaceuticals on cardiac structures are based 
on the reliable and accurate evaluation  results of in vitro and in vivo experiments that asses the 
effects of the drug or extract in its physiological environment (Hanton, 2007). 
 
The in vivo methods are concerned with measuring the effect of the drug on electrical or 
mechanical performance of the heart and cardiovascular system. The effect of the mechanical 
performance of the heart in vivo can be evaluated in terms of the blood pressure and heart rate 
whereas the actions on electrical properties are characterized by an electrocardiogram (EKG) 
(Pugsley, 2003). Some of the in vivo methods include: direct measurement of blood pressure 
in conscious rat with indwelling catheter, blood pressure measurements in the pithed rat, tail 
cuff methods and hemodynamic screening in anesthetized rats (Pugsley, 2003). The 
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measurement of blood pressure in conscious rat is restricted to two methods. The direct and 
indirect methods (Kamadyaapa, 2008).  
 
Indirect methods are non-invasive methods of measuring blood pressure, the most common 
indirect method used in rodent studies is the use of a tail cuff device.  Advantages of indirect 
methods is that they are less demanding technically and they are suitable for chronic studies 
since serious risks to animal health are minimal (Vliet et al., 2001). The main limitation of this 
method is that it is indirect, discontinuous and requires restraint of animals.  In some cases 
heating of the animal is used in order to enable sufficient blood flow to ensure easy 
measurement. But this is a problem as the combination of warming and restraint can lead to 
significant increases in core body temperature, and then affect blood pressure. Therefore the 
result of blood pressures obtained with the tail-cuff method may not only reflect the animal 
blood pressure, but also the reactivity of blood pressure to the stress of the procedure (Vliet et 
al., 2001). Due to these limitations, the direct method is use to verify blood pressure 
measurement  results from the tail-cuff method (Kamadyaapa. ,2008). 
 
Direct methods use techniques by which arterial blood pressure is measured directly with the 
aid of a sensor device (catheter) that is implanted invasively within a suitable artery. The sensor 
is connected to a calibrated pressure transducer for blood pressure measurement (Vliet et al., 
2001). This is the most accurate method of blood pressure measurement. The major advantages 
http://etd.uwc.ac.za/
37 
 
of this method are: the cost of materials needed for the procedure are inexpensive and precise 
calibration is easier as the whole procedure can be performed under normal physiological 
conditions without involving the warming and restraining of the animals. This procedure allows 
for continuous long-term blood pressure recordings under conditions of relatively low stress. 
Major disadvantages is that the catheter implantation surgery and anaesthesia causes 
disturbance to the animal, its blood pressure and heart rate (Vliet et al., 2001). Another 
limitation is based on the fact that if the procedure is not done properly it can create potentials 
for infection and potential for loss of catheter patency. This may lead to a degradation or loss 
of blood pressure signal resulting in limited dynamic response, which makes detection of the 
true systolic and diastolic pressures challenging in small animals with high heart rates (Vliet et 
al., 2001).  
 
Many types of in vitro cardiac preparations are used to study cardiac function and the 
electrophysiological effects of drugs on myocardial cells. Methods include: isolated cardiac 
tissue preparation, single myocardial cells, the Langendorff isolated rat heart, heterologous 
expression system, inhibition of ACE inhibitors in vitro, and renin inhibitory activity using 
human kidney renin and a synthetic substrate (Pugsley, 2003). 
 
Perfused organ preparations such as the modified Langendorff technique and the working heart 
preparation have been used to assess integrative myocardial function in vitro upon exposure to 
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different drugs and toxins (Partridge, Johnson and Ramos, 2005). The isolated heart model 
such as the Langendorff heart makes it possible for a broad range of physiological and 
pharmacological studies to be done, as well as removing false effects of other organ systems. 
The working preparation is perfused through the left atrium to generate a left-sided working 
preparation. The perfusion fluid reaching the ventricle is ejected via the aorta into a chamber 
against hydrostatic pressure to mimic physiological resistance to flow (Partridge, Johnson and 
Ramos, 2005) . The advantage of perfused preparation in toxicological studies is that the  level 
of structural organization is similar to that encountered in vivo, and changes in physiological 
or pharmacological sensitivity, excitability and contractility can be easily be monitored. The 
most major limitations of perfused preparations are the small number of duplicate preparations 
that can be handled at any one time, and the time available for isolation and placement of the 
tissue under physiological conditions is short (Partridge, Johnson and Ramos, 2005). 
 
Isolated muscle preparations include isolated atrial or ventricular tissue, papillary muscle and 
isolated coronary right ventricular wall. The small size of the cardiac tissue allows for the rapid 
and continuous diffusion of oxygen and nutrient to subcellular layers resulting in viable stable 
preparation. Advantage of this approach provides more to the study of cardiac drugs on the 
mechanical, electrical and biochemical properties of the heart. It is also a sensitive indicator of 
chronotropic and inotropic action on the heart. (Pugsley, 2003). 
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Drug discovery studies on anti-hypertensive drugs have developed rapidly since the discovery 
of ACE. The ACE inhibitory activity has become an effective screening method in the search 
for new anti-hypertensive drug from herbal plants. The activity of ACE inhibition by in vitro 
methods have become an effective assay method in identification of active anti-hypertensive 
molecule (Ahmad et al., 2017). The in vitro assay methods used to determine the activity of 
ACE inhibitors are based on the substrate usage by the ACE enzyme. These assays includes: 
Cushman and Cheung Method which uses a substrate hippuryl-histidyl-leucine (HHL); 
Holmquist method uses  furanacryloyl-tripeptide as a substrate; Elbl and Wagner method uses 
a substrate benzoil-[l-14C] glicyl-L-histidine-L-leucine; Carmel and Yaron method uses o-
aminobenzoylglycyl-p-nitrophenylalanilproline as a substrate; and Lam method uses 3-
hydroxybutyrylglycyl-glycyl-glycine as substrate.  There are several different methods that are 
used to measure the results of enzymatic reactions or separation of the substrate with products. 
These methods includes spectrophotometric, fluorometric, high-performance liquid 
chromatography, electrophoresis, and radiochemistry. The application of these methods for 
screening the ACE inhibitors activity and identification of active compounds from natural 
products provides results that are simple, accurate and rapid. The most common ACE inhibitory 
activity tests is the Cushman and Cheung method and Elbl and Wagner methods (Ahmad et al., 
2017). 
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Cushman and Cheung assay method measures the activity of ACE inhibitors by using hippuryl-
histidyl-leucine (HHL) subtract. In the presence of the ACE, the HHL is hydrolysed into 
Hippuric acid (HA) which can be measured at a wavelength of 228 nm using an ultraviolet-
visible (UV-Vis) spectrophotometer instrument. When there is ACE inhibition, the 
concentration of HA formed will be reduced. This reaction is visualized by the means of 
fluorescence which occurs when o-Phthaldialdehyde (OPA) is added to the assay solution. 
OPA reacts with the cleaved substrate and is measured by a fluoro-colorimeter instrument at a 
wavelength of 495 nm emission and 365 nm excitation. Elbl and Wagner assay uses the 
chromophore- and fluorophore-labeled tripeptide dansyl triglycine as substrate. The substrate 
is cleaved by the ACE into dansylglycine and diglycine and this is separated by RP-HPLC. 
These techniques have limitations, such as being very laborious and having low sensitivity in 
terms of determining if inhibition is due to any external factors (Ahmad et al., 2017). 
 
 
2.8 The renin-angiotensin-aldosterone system in cardiovascular 
disease  
 
Angiotensinogen is converted to angiotensin I by renin after it has been released from the liver 
into the circulation. Renin is a proteolytic enzyme which synthesized, stored and released 
largely from the juxtaglomerular apparatus in the kidneys when there is a decrease in blood 
pressure, low sodium concentration and increased sympathetic activity. Angiotensin 1 has a 
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mild vasoconstrictor effect, but that’s not enough to achieve a significant physiological effect. 
Angiotensin I is converted to angiotensin II by angiotensin converting enzyme as well as other 
enzymes such as chymase, cathepsin, and tonin. Angiotensin II inhibits renin through the 
process of negative feedback, thereby acting in a self-regulatory manner. Angiotensin II is a 
multi-functional peptide that acts on different tissues; in the adrenal gland it stimulates the 
release of aldosterone and causes the constriction of renal arterioles, consequently, increasing 
salt and water retention in the kidneys. It is involved in the regulation of salt and fluid 
homeostasis in the brain by influencing the autonomic nervous system, vasopressin release. In 
the blood vessels, it acts as a powerful vasoconstrictor as well as remodelling the vascular wall 
through stimulation of smooth muscle cell growth, up-regulation of growth factors and by 
affecting the synthesis of extracellular matrix proteins. In the heart, it has inotropic and 
hypertrophic effects and promotes cardiac fibrosis. Also, it is involved in inflammation by 
enhancing up regulation of endothelial adhesion molecules, pro-inflammatory cytokines and 
production of reactive oxygen species (Ljungberg, 2011). 
 
2.9 Angiotensin converting enzyme and its inhibitors  
 
ACE is a glycoprotein with peptidyl dipeptide hydrolase that breaks up angiotensin I to produce 
angiotensin II in the blood. The vasoconstrictive action of angiotensin II, its simulation of the 
synthesis and release of aldosterone is so powerful that it has a consequent increase in arterial 
blood pressure. ACE also hydrolyses and inactivates a peptide bradykinin which has 
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vasodilatory actions (Afonso et al., 2013a). ACE inhibitors work by inhibiting the conversion 
of angiotensin 1 to the potent vasoconstrictor angiotensin II, therefore improving blood flow 
and blood pressure. Angiotensin II is a hormone that circulates in the bloodstream which causes 
constriction of the blood vessels and increases the work required by the heart to pump blood 
into the body’s main arteries. It also acts as growth hormone that increases the size or thickness 
of many cardiovascular structures, hence high levels of circulating angiotensin II eventually 
leads to a condition known as hypertrophy characterised by the thickening and stiffening of the 
heart muscles (Sweitzer, 2003). This can be a problem for the heart muscle if it has already 
been weakened by a heart attack or heart failure. In many cardiovascular diseases, angiotensin 
II is present in abnormally high quantities. Therefore, ACEIs’ are prescribed to reverse the 
hypertrophy of the heart and vessel walls (Sweitzer, 2003). The use of synthetic modern ACE 
inhibitors such as captopril, enalapril and lisinopril provide definitive positive health effects 
and is considered as an important therapeutic approach in the treatment of high blood pressure 
(Simaratanamongkol et al., 2014; Vijayan, Chitra and Penislusshiyan, 2018). ACEIs has three 
distinct chemical structures namely: sulfhydryl containing agents (captopril), the non-
sulfhydryl containing agents and the phosphoric acid derivatives (fosinopril). These inhibitors 
bind to the zinc ion in the ACE molecule through their sulfhydryl and phosphoric acid moieties 
whereas other inhibitory agents bind to the zinc through carboxyl residues. ACEIs are still 
considered effective and safe for the treatment of hypertension as their anti-hypertensive effect 
are enhanced through low salt diet and their pharmacological actions including vasodilation, 
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increased sodium excretion, diuresis and lowering blood pressure. ACEIs are well tolerated 
and has a high safety profile, although they are not safe in pregnancy.(Duncan A C, 1998). 
 
Certain herbal preparations have been found to inhibit ACE, and the evidence that certain 
flavonoid-rich natural products can induce reductions in blood pressure and inhibit ACE 
activity opens the possibility that their consumption may mimic synthetic ACE inhibitors and 
provide preventive health benefits while avoiding the associated adverse effects. (Afonso et 
al., 2013a). Tannins are polyphenol plant compounds that precipitate proteins and interfere 
with the activities of ACE macromolecules. Any plant extract with ACE inhibition ≥50% needs 
to be tested for the presence of tannins so to eliminate false positive results. (Afonso et al., 
2013b). 
 
 
2.10 Bioassay-guided isolation 
 
Bioassay-guided fractionation is a process whereby extracts are chromatographically 
fractionated and re-fractionated until an active biological compound is isolated. Each of the 
fractions produced during the process is evaluated in a bioassay system and then only the active 
fractions re-fractionated. This process is often employed in drug discovery because of its 
effectiveness in directly linking the analysed extract or compound isolated using the 
fractionation process with a certain biological activity (Sowers, Epstein and Frohlich, 2001). 
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Bioassays are divided into two methods namely: diffusion and dilution methods. In diffusion 
methods, the active compounds have to diffuse into a medium containing the target organism 
whereas, in dilution methods, the metabolites and the target organism dissolve in the medium. 
The disadvantage of diffusion bioassays is that the medium may interfere with  inhibitory 
action of the active compounds thereby giving false results, whereas  with dilution bioassays, 
finding solvents in which the active compound is soluble in might be difficult (Panuganti, 
2015). 
 
Isolation of biologically active metabolites from plant materials is achieved following the steps 
of sample preparation, separation, isolation and enrichment, accompanied by a suitable 
bioassay. In this study, extracts of Hypericum perforatum and fractions obtained from 
chromatography were screened to determine the compound with ACE inhibition activity using 
an in vitro fluorometric ACE inhibition assay-guided fractionation. HPLC was employed for 
purification, and NMR, IR and MS were used for identification and structural elucidation of 
the isolated bioactive compound.  
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CHAPTER 3 
MATERIALS AND METHODS 
 
This chapter describes the techniques used in the extraction, isolation and purification of the 
active compound from Hypericum perforatum crude extract. It also describes in detail the assay 
used in evaluating the ACE inhibitory activity of the extract and the compound isolated from 
Hypericum perforatum. The methodology used for structural elucidation and identification of 
the pure active compound by NMR, FTIR and MS are also discussed below. 
3.1 Material  
 
Chemicals and consumables  
Dried and ground Hypericum perforatum was purchased from Warren Chem Specialities 
PTY LTD (Cape Town, South Africa) and authenticated and certificate of analysis was 
provided by DIXA AG Company and deposited to the University of the Western Cape, 
School of Pharmacy lab where it was stored in an air tight container until needed. See 
appendix VI for certificate of analysis. 
The solvents (ethanol, ethyl-acetate, hexane, and methanol) used in the extraction and 
isolation process were purchased from KIMIX chemical and Laboratory suppliers (Cape 
Town, South Africa).   
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ACE enzyme, O-phthaldialdehyde (OPA), L-hippuryl-L-histidyl-L-leucine (L-hip-Lhis-L-
lue) (HHL), Boric acid, sodium chloride, enalapril, and captopril used in the bioassay were all 
purchased from Sigma Aldrich (Cape Town, South Africa). 
 
Equipment   
The TLC tank, TLC aluminium sheets (20 cm x 20 cm; F254), Whatman filter paper and silica 
gel (60 mesh) were purchased from Sigma Aldrich (Cape Town, South Africa). Evaporation of 
excess organic solvent was carried out using a Buchi Rotavapor R-200, Buchi heating bath B-
400, Buchi Vac V-500 (all Buchi Labor Technik, Flawil, Switzerland). Aqueous samples were 
frozen using a minus -86 ultra-freeze (NuAire, Plymouth, USA.), and freeze-dried using a 
Sentry 2.0 freeze dryer (Virtis SP scientific, Pennsylvania, USA). Fluorometric visualization 
of the ACEI bioassay was carried out using a GBC CINTRA 2020 UV-Vis spectrophotometer 
(Hampshire, USA). HPLC separation was carried out on an Agilent HPLC system (Bruker, 
Germany), and NMR experiments were run on a Bruker Avance 400 MHz spectrometer 
(Bruker, Rheinstetten, Germany). IR spectrum was acquired using a Perkin Elmer spectrum 
400 FT-IR/FT-NIR spectrometer (Perkin Elmer Inc. Waltham, USA) and Mass spectroscopic 
analysis was carried out on Leco Pegasus HRT, GC×GC-high resolution MS (LECO 
cooperation, St Joseph, USA).  
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3.2. Plant preparation and extraction  
 
To prepare organic and aqueous extracts of the plant, 1 kg of finely grounded powder of 
Hypericum perforatum was macerated in 1.5 L of ethanol (99.9%) and distilled water 
respectively for 48 hours with frequent agitation. Both extracts were filtered using Whatman 
No.1 filter paper and the solvent removed under vacuum by rotary evaporator at 40oC (ethanol 
extract) or freeze-dried (aqueous extract) to yield ethanol and aqueous extracts, respectively. 
The extracts were weighed 245.29 g w/w for ethanol extract and 24.96 g w/w (̴25% yield for 
ethanol extract and 2% for aqueous extract) and stored at 4oC in air-tight containers until 
required.  
Both ethanol and aqueous extracts were tested for ACEI activity using the ACEI assay as 
described by Cushman and Cheung (1971) with some modifications (see section 3.6). The 
extract that exhibited the active greater inhibition of ACE was used further for the purpose of 
this study.  
 
3.3 Fractionation of ethanol extract  
 
3.3.1 Column chromatography parameters 
A 1.2 meter, 5 cm diameter glass column was used in the fractionation of extracts. The 
stationary phase comprised of 100 g silica gel (70-230 mesh) tightly packed into the column, 
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while the mobile phase comprised of a mixture of ethyl acetate and hexane , using a gradient 
elution method running from non-polar to polar solvent (see table 3.1).  
 
TABLE 3. 1 COLUMN GRADIENT ELUTION PARAMETER 
Fraction Volume  Solvent  
1 500 ml Hexane (100%) 
2 500 ml  Hexane: Ethyl acetate (80%:20%) 
3 500 ml Hexane: Ethyl acetate (60%:40%) 
4 500 ml  Hexane: Ethyl acetate (40%:60%) 
5 500 ml  Hexane: Ethyl acetate (20%:60%) 
6 500 ml  Methanol: Ethyl acetate (50%: 50%) 
7 500 ml  Methanol (100%) 
 
 
3.3.2 Column fractionation 
 
Hypericum perforatum ethanol extract (10 g) was dissolved in 25 ml of ethanol, the solution 
adsorbed on a small amount of silica gel (35-60 mesh) to make a slurry and excess solvent 
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evaporated using a rotary evaporator to yield ethanol extract granules. The granules were 
applied on the top of the stationary phase bed, covered with absorbent cotton to avoid 
disturbance in the sample and eluting solvent run on a gravity feed using the protocol stated in 
table 3.1. Collected fractions were spotted on TLC plates to visualize the compounds contained 
in each fraction. Fractions containing similar profile of compounds were combined, the excess 
solvent removed and the fractions tested for bioactivity using the ACEI bioassay (see section 
3.6). Figure 3.1 shows systemic flow of how fractions were obtained. 
 
3.4 Purification of active fraction  
 
The HPLC separation was performed using an Agilent standard cell 1260 infinity HPLC 
system. (Agilent technologies, Germany), coupled with variable UV wavelength detection at 
254 nm and refractive index detector (RID). The partially pure active compound (F5) (100 mg) 
eluted from column fractionation was subjected to normal phase preparative HPLC for 
purification. In this method, ethyl acetate (80%) and hexane (20%) were used as mobile phase 
at a flow rate of 3 ml/min, and injection volume of 200 µl for a total time of 35 minutes for 
each injection. All analyses were carried out at a temperature of 30oC and bar pressure of 50.73 
psi. 
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FIGURE 3. 1: ISOLATION PROCESS FROM ETHANOL EXTRACT OF HYPERICUM 
PERFOATUM  
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3.5 Structural determination of bioactive compounds  
3.5.1 NMR spectroscopy  
 
NMR spectrometer was equipped with a 5 mm BBO probe at 298 K using standard 1D and 2D 
NMR pulse sequences. All spectra were referenced to residual undeuterated solvent peaks 
(Ahmed et al., 2004). 1D NMR including both 1H NMR and 13C NMR experiments were used 
to locate atom positions and fragment units. 2D NMR including COSY, HSQC, and HMBC 
was carried out to obtain a more accurate assignment of proton and carbon chemical shift. 
About 5 mg of purified compound was dissolved in 0, 5 ml of deuterated chloroform (CDCl3). 
Signals were recorded in chemical shifts δ and expressed in parts per million (ppm).  
  
3.5.2 Fourier Transform infrared (FTIR) spectroscopy 
 
 Fourier Transform infrared spectroscopy spectra were recorded for Hypericum perforatum 
active pure compound on Perkin Elmer spectrum 400 FT-IR/FT-NIR spectrometer version 
6.3.50176 software. A small amount of properly triturated sample was placed on the crystal of 
a PerkinElmer FTIR Spectrometer (Spectrum 400, PerkinElmer, USA). Pressure was applied 
gradually using the pressure gauge between 50 and 60%. A resolution of 4 cm–1 and a scanning 
range of 500 to 4000 cm–1 were used. Resulting peaks were compared to published data of 
functional groups.  
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3.5.3 Gas chromatography- mass spectroscopy (GC-MS) 
 
The pure active extract was subjected to GC-MS analysis. The GC-MS spectroscopic study 
was carried out using Leco Pegasus HRT, GC×GC-high resolution MS. A 1D: 30 m × 0.25 
mm, 0.25 μm df Rxi-5MS (Restek) column was used. The carrier gas was helium at a constant 
flow rate of 1 mL/min. The injector temperature was set at 40°C for 2  minutes, then increased 
by 20°C/min to 220°C  and held for 15 min. Injections of 1 μl were made in a split mode with 
a split ratio of (1:20). The mass spectrometer was operated in the electron ionization mode of 
(70eV); HR TOF-MS, m/z 5-520, 13 Hz. 
 
 
3.6 ACE inhibitory assay 
 
Inhibition of ACE activity by the fractions and isolated compound was assessed according the 
method of Cushman and Cheung (1971), modified by Liberman (1975). In this method, L-
hippuryl-L-histidyl-L-leucine (L-hip-Lhis-L-lue) (HHL) acts as the enzyme substrate and 
enzyme inhibition is measured as the reduction in fluorescent produced when the cleaved 
portion of HHL (histidyl-leucine) binds to O-phthaldialdehyde (OPA). The following steps 
describe ACE inhibitory assay procedure that was used in this study. 
 
http://etd.uwc.ac.za/
53 
 
3.6.1 Angiotensin converting enzyme inhibitory assay 
 
 This assay was carried out in a 25 µl incubation mixture containing 4 µl of  inhibitor solution 
(plant extract/fractions/purified compound) at different concentrations, 15.4 µl sodium borate 
buffer containing a mixture of 0.4M Boric acid and 0.3M sodium chloride (pH 8.3) and 5.6 µl 
of the enzyme, pre-incubated for 20 minutes. . The blank sample was prepared by replacing the 
inhibitor solution with the sodium borate buffer. The control sample was prepared by replacing 
the inhibitor with captopril. The reaction was then initiated by the addition of 10 µl of 116.4 
mM hippuryl histidyl-leucine (HHL) substrate and the reaction mixture was incubated at 37oC 
for 60 minutes. The reaction was then terminated by adding l50µl of 0.34M NaOH, and then 
20 µl of 20 mg/ml OPA added to the reaction mixture and incubated for 10 minutes. The 
reaction was stopped after incubation by adding 50µl of 3M HCl. Black 96 well-plates 
containing the various inhibitor concentrations in the reaction mixture was introduced to the 
fluorescent plate reader (make) with parameters set at 355 nm excitation and 535 nm emission 
frequency. The ACE activity or inhibition of ACE activity was obtained by fluorometric 
determination of the amount of histidyl-leucine (His-Leu) cleaved by the ACE enzyme of 
which was made visible with o-Phthaldialdehyde (OPA) through the use of UV-VIS 
spectrophotometer. The percentage inhibition of the sample was calculated using the following 
equation  
%𝑝𝑒𝑟𝑒𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =
fluroscent enzyme control − fluroscent sample
fluroscent enzyme control − fluroscent blank
𝑋 100 
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CHAPTER 4 
RESULTS AND DISCUSSION 
 
Due to the contribution of hypertension to various cardiovascular diseases, many studies are 
currently focused on identifying efficient bioactive compounds with antihypertensive activity 
and thus reducing the levels of cardiovascular disease. ACE inhibitors are an important 
component to the therapeutic regimen for treating hypertension, but due to the increase in the 
prevalence of side effects of synthetic compounds, alternative and complementary medicines 
which may consist of pure bioactive compound or a combination of various compounds from 
natural sources are gaining importance in overcoming hypertension. Hypericum perforatum 
has been studied for various activities including anti-bacterial, anti-depressant, anti-oxidant 
properties, but studies on its cardiovascular effects specifically ACE inhibitory activity have 
not yet been explored. In this study, ACEI assay-guided fractionation of the ethanol extract of 
Hypericum perforatum was carried in other to isolate a compound with ACE inhibition. A 
compound isolated from an active fraction of the plant extract was tested for ACE inhibition 
and its chemical structure elucidated. The results of the structure elucidation of the compound 
isolated from Hypericum perforatum as well as the ACE inhibition experiments is presented in 
this chapter. 
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4.1.0 Structure Elucidation of the compounded isolated  
 
The ethanol crude extract of Hypericum perforatum was subjected to column fractionation, and 
re-fractionation guided by ACE inhibition activity of the fractions. Fraction (F5) was assumed 
to contain the main ACE inhibiting compound because it showed higher percentage of ACE 
inhibition. Therefore, fraction (F5) was subjected to normal phase HPLC purification, and the 
pure active fraction - F54 identified using NMR spectroscopic techniques and literature data. 
The pure compound was isolated as a colourless oil and a final weight of 10 mg of pure 
compound was recovered from 100 mg of ethanol extract (F5) and its percentage yield was 
calculated to be 0.001% (w/w). The low percentage yield could be due practical loss of material 
during the re-fractionation process. The structure of compound were determined using 1H and 
13NMR, DEPT, HSQC, HMBC and by comparison of data from literature. The pure active 
compound was previously reported as a hydroxylactone, and the molecular formula C6H10O3 
was confirmed by C-NMR, DEPT and GC-MS analysis and the structure is presented in figure 
4.6. The isolated hydroxylactone was identified as 3-hydroxy 4, 4 dimethyl-4-butyrolactone 
and this is the first time it has been isolated from Hypericum perforatum.   
 
4.1.1 NMR  
 
The 1H-NMR spectrum of compound 1 showed typical signals of two methyl groups: two 
singlets at  1.48 (H-5) and 1.41 (H-6) and their carbon signals at  21.1 (q) and 26.1 (q), 
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respectively. The downfield proton signal which appeared as a doublet of doublets at d 4.20 (J 
= 3.5, 6.5 Hz) correlated with an oxygenated carbon signal at 73.6 in the HSQC spectrum. 
The limited quantity of 1 gave only poor 13C and DEPT-135 NMR spectra; therefore 13C NMR 
chemical shifts were obtained from edited-HSQC and HMBC spectra. The presence of 
downfield quaternary carbon signal at d 87.7 in the 13C-NMR suggested the presence of a 
second oxygenated carbon. 13C NMR chemical shifts at 173 ppm indicated the presence of a 
carbonyl moiety. The assignment of all proton signals and their connectivity to carbons was 
established from the results of the 1D and 2D NMR, COSY, HSQC and the long range coupling 
HMBC experiments. Data from the 1H NMR and 13C NMR are summarized below. Full set 
NMR spectra are presented below and also in appendix I-III. 
 
TABLE 4. 1:1H NMR (400 MHZ) AND 13C NMR (100 MHZ) DATA FOR PURE COMPOUND IN CDCL3 (Δ 
IN PPM AND J IN HZ) AND BY COMPARISON OF DATA WITH LITERATURE  ( (Ahmed et al., 2004) 
Atom no δH δC* Type HMBC to  Literature 
values (δH) 
(Ahmed et 
al., 2004)   
Literature 
values (δC) 
(Ahmed et 
al., 2004) 
1 - 173.0 C   174.2 
2a 2.55, dd,  J = 17.9, 
3.3 
38.1 CH2 C-1 2.52 38.2 
 2b 2.95, dd, J = 17.9, 
6.6 
38.1  C-1 2.91 38.2 
3 4.21, J = 6.3, 3.3,  73.6 CH C-2 4.20 73.8 
4 - 87.7 C   87.6 
5 1.41, s 26.1 CH3 C-3, C-4, 
C-6 
1.38 21.0 
6 1.43, s 21.1 CH3 C-3, C-4, 
C-6, 
1.44 26.1 
* 13C NMR chemical shifts were obtained from edited-HSQC and HMBC NMR 
spectra 
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FIGURE 4. 1 : 1H SPECTRUM OF 3-HYDROXY 4, 4 DIMETHYL-4-BUTYROLACTONE 
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FIGURE 4. 2:  HSQC SPECTRUM OF 3-HYDROXY 4, 4 DIMETHYL-4-BUTYROLACTONE 
 
 
FIGUR E 4. 3 : HMBC SPECTRUM OF 3-HYDROXY 4, 4 DIMETHYL-4-BUTYROLACTONE 
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4.1.2 FTIR  
 
The IR spectroscopy was used to confirm any functional groups present in the isolated 
compound and the spectra were recorded with Perkin Elmer spectrum 400 FT-IR/FT-NIR 
spectrometer version 6.3.50176. The infrared spectrum of the isolated compound indicated 
strong bands at 3408.44 (O-H), 2926.03 (C-H), and 1748.86 (C=O) cm–1  
 
FIGURE 4. 4:  FTIR SPECTRUM OF 3-HYDROXY 4, 4 DIMETHYL-4-BUTYROLACTONE 
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4.1.3 MS  
 
GC-MS was used to confirm the molecular formula of the compound as predicted by NMR and 
IR data. The GC-MS experiments could not observe the molecular ion (m/z 130) of the 
compound however, a peak corresponding to the loss of H2O from the parent molecule (m/z 
112) was observed.  Loss of H2O from secondary alcohols with alpha protons are quite 
common. Computing the molecular weight from the molecular weight of the fragment ions 
resulted in a molecular formula - C6H10O3 and a molecular weight - 130, which was consistent 
with the proposed structure of the compound as predicted by NMR  
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 FIGURE 4. 5:  GC-MS DATA OF 3-HYDROXY 4, 4 DIMETHYL-4-BUTYROLACTONE 
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A thorough search of literature and database including SciFinder®, ChEMBL®, chemsearch®, 
Molbase® and Pubchem® of chemical structures indicated that this is the first time this 
compound has been isolated from Hypericum perforatum. The isolated pure compound was 
identified and confirmed by the NMR spectra in literature to be 3 hydroxy 4, 4-dimethyl-4-
butyrolactone, with a molecular weight of 130 and molecular formula of C6H10O3. (figure 4.6) 
(Ahmed et al., 2004). The compound belongs to a class of organic compounds known as 
lactones, and contains a gamma butyrolactone moiety which consists of an aliphatic five 
member ring with four carbon atoms, one oxygen atom and a ketone group on the carbon 
adjacent to the oxygen atom. The oxygen atom is double bonded to a carbon atom. The carbon 
atoms are attached to another oxygen atom that forms part of a closed ring (fig 4.6). 
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FIGURE 4. 6: 3-HYDROXY 4, 4 DIMETHYL-4-BUTYROLACTONE 
 
 
 
FIGURE 4. 7: 3D REPRESENTATION OF 3-HYDROXY 4, 4 DIMETHYL-4-BUTYROLACTONE 
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4.2 In vitro bioassay-guided isolation 
 
Both aqueous and ethanol crude extracts of Hypericum perforatum were first tested for ACE 
inhibition as various concentrations (200 mg/ml, 100 mg/ml, 10 mg/ml and 1 mg/ml) using a 
modified version of the method as described by Cushman and Cheung (1971) (see section 3.6 
of chapter 3). Dose-dependent ACE-inhibition was observed with both extracts, with the 
highest ACE-inhibition observed with the highest concentration (200 mg/ml) of both extracts 
(99.53% with the ethanol extract and 98.83% with the aqueous extract). Enzyme inhibition 
observed with the highest concentrations of both extracts was comparable to that obtained with 
the standard drug captopril (98.58% inhibition with a 1 mg/ml concentration) (see table 4.2). 
Both ethanol and aqueous extract showed good inhibitory activity, with a slightly greater 
activity from the organic extract. 
 
TABLE 4. 2: ACEI BIOASSAY ACTIVITY OF THE ORGANIC AND AQUEOUS EXTRACTS OF HYPERICUM 
PERFORATUM 
Concentration  1 mg/ml 10 mg/ml 100 mg/ml 200 mg/ml 
Ethanol crude extract (%inhibition)  87.11% 97.09% 98.31% 99.53% 
Aqueous crude extract (% inhibition) 86.46% 96.15% 97.64% 98.83% 
Captopril  (% inhibition) 98.58%    
.   
http://etd.uwc.ac.za/
65 
 
Due to this greater ACE-inhibitory and a greater yield (25% yield for organic extract and 2% 
yield for aqueous extract), the organic extract was selected for further bioassay guided 
fractionation according to the method described in section 3.3 of chapter 3. 
 
The ACE inhibitory activity of each fraction (1 mg/ml) from the gradient elution of the organic 
extract was tested for angiotensin converting enzyme inhibition using the bioactivity assay (see 
section 3.6; Chapter 3). Fraction F5 that eluted with ethyl acetate: hexane (80:20) mobile phase 
produced the highest inhibition of enzyme activity with a percentage inhibition of 70.03% at a 
concentration of 1mg/ml, with all other fractions producing enzyme inhibition below 45% 
(Table 4.3).  
 
 
TABLE 4. 3: ACE BIOASSAY ACTIVITY OF FRACTIONS (1MG/ML) FROM GRADIENT ELUTION OF 
ETHANOL EXTRACT OF HYPERICUM PERFORATUM. 
FRACTIONS  F2 
(H:E) 
80:20 
F3 
(H:E) 
60:40 
F4 
(E:H) 
60:40 
F5 
(E:H) 
80:20 
F6 
100%  
EtOAc 
F7 
(M:E) 
1:1 
F8 
100% 
CH3OH 
% 
INHIBITION 
3.5% 4.4% 32.83% 70.03% 16.76% 44.70%  7.3% 
 
http://etd.uwc.ac.za/
66 
 
The most active fraction (F5) was then assumed to contain the main ACE inhibiting compound, 
and was subjected to further fractionation using HPLC (see section 3.4; Chapter 3) and ACE 
bioactivity assay (see section 3.6; Chapter 3).  
 
HPLC fractionation of fraction F5 yielded five fraction peaks (F51 – F55) eluting at different 
times (8, 9, 10, and 20 and 24 minutes for fractions F51 to F55 respectively). All eluted fractions 
were tested for activity using the ACE assay (see section 3.6; Chapter 3), and produced enzyme 
inhibition (-1.86%, 43.77%, 49%, 71%, 17.83% respectively for fractions F51 to F55) at a 
concentration of 1 mg/ml (table 4.4). The ethyl acetate wash and a combination of all fractions 
with no distinct HPLC peaks produced 26.36% and 25.07% inhibition of enzyme activity 
respectively at a concentration of 1 mg/ml (table 4.4). 
 
TABLE 4. 4: ACE BIOASSAY ACTIVITY OF FRACTIONS (1MG/ML) FROM HPLC FRACTIONATION OF 
FRACTION F5 FROM THE ETHANOL EXTRACT OF HYPERICUM PERFORATUM. 
Fractions  F51 F52 F53 F54 F55 Ethyl 
acetate  
No peaks 
fraction 
% inhibition -1.8% 43.77% 49% 71% 17.83% 26.36% 25.07% 
 
The most active fraction (F54) was characterized using NMR, indicating it was a pure 
compound and further structure elucidation as described in section 3.5; chapter 3 was carried 
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out to identify the compound as 3-hydroxy 4, 4 dimethyl-4-butyrolactone (see section 4.1 and 
figure 4.6). 
 
The IC50 for 3-hydroxy 4, 4 dimethyl-4-butyrolactone was determined using different 
concentrations (40, 80, 160 and 480 µg/ml) (see table 4.5). The isolated compound had an IC50 
value of 63.88 μg/ml, comparable to the IC50 of captopril (0.0165 µg/ml). Non- linear 
regression analysis indicated the R2 value for 3-hydroxy 4, 4 dimethyl-4-butyrolactone and 
captopril as 0.9947 and 0.8291 respectively (see figure 4.8 and 4.9) 
 
TABLE 4. 5: ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORY ACTIVITY OF 3-HYDROXY 4, 4 
DIMETHYL-4-BUTYROLACTONE, ISOLATED FROM THE ORGANIC EXTRACT OF HYPERICUM 
PERFORATUM AND CAPTOPRIL, THE STANDARD ACE INHIBITOR.  
Extract/ drug ( concentration) % inhibition of ACE activity 
F54 (40 µg/ml) 28.89% 
F54(80 µg/ml) 70.72% 
F54(180 µg/ml) 71.53% 
F54(480 µg/ml) 92.76% 
Captopril (1 ng/ml) 17.7% 
Captopril (10 ng/ml) 42.4% 
Captopril (100 ng/ml) 74.3% 
Captopril (1000 ng/ml ) 95.6% 
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FIGURE 4. 8: IC50 PLOT FOR THE ACE INHIBITORY EFFECT OF 3-HYDROXY 4, 4 DIMETHYL-4-
BUTYROLACTONE, ISOLATED FROM THE ORGANIC EXTRACTS OF HYPERICUM PERFORATUM. 
 
 
 
FIGURE 4. 9: IC50 PLOT FOR THE ACE INHIBITORY ACTIVITY OF CAPTOPRIL 
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4.3 Discussion  
 
This study investigated the potential of Hypericum perforatum as a new source of compound(s) 
with inhibitory activity against ACE. About 1 kg of crude powdered Hypericum perforatum 
was macerated in ethanol to obtain a gummy red ethanol extract with a 25% yield. The resulting 
ethanolic extract was subsequently subjected to fractionation via gradient elution on a silica 
gel column using different ratios of ethyl acetate and hexane as solvent system. The ACEI 
assay-guided fractionation of the organic extract of Hypericum perforatum yielded fraction 5 
with percentage inhibition of 70.03%, with further HPLC fractionation yielding the most active 
fraction (F54), which was characterized using NMR and GC-MS to identify the structure (3-
hydroxy 4, 4 dimethyl-4-butyrolactone), molecular weight (130) and molecular formula 
(C6H10O3). An IC50 value of 63.88 μg/ml and an R2 value of 0.8291 was calculated.  
 
3-hydroxy 4, 4 dimethyl-4-butyrolactone is a hydroxylactone which are subclass of lactones. 
Lactones have a broad pharmacological profile making them compounds of interest as lead 
structures for the development of new drug entities. Pharmacological activities reported with  
lactones include: antibacterial, antimalarial, anti-viral, antifungal, anti-helminthic, anticancer, 
anti-inflammatory and cytostatic properties (Kozioł et al., 2017). Hydroxylactone  are 
classified as natural lactones and  have been isolated from a number of African traditional 
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medicinal  plants in a very small percentages and normally appear as essential oils (Seitz and 
Reiser, 2005; Buckle, 2015).  
 
In this study 3-hydroxy 4, 4 dimethyl-4-butyrolactone was isolated from Hypericum 
perforatum. 3-hydroxy 4, 4 dimethyl-4-butyrolactone has been previously isolated from other 
plants including some hypericum spp, with documentation of its various pharmacological 
activities in literature. It was extracted as a natural product for the first time from Hypericum 
hircinum used as a monoamine oxidase inhibitor (Chimenti et al., 2006). It was also extracted 
from Anaphalis margaritacea (L.), a plant widely used by many Native American tribes across 
North America to treat respiratory problems and rheumatism and evaluated for its antibacterial 
activities, although no activity was reported on the compound (Ahmed et al., 2004). It was one 
of  the compounds isolated from the leaves of Clusia burlemarxii and tested for antimicrobial 
activity against Streptococcus mutans, Staphylococcus aureus, Bacillus subtilis, Micrococcus 
luteus, Escherichia coli, Salmonella choleraesuis, Pseudomonas aeruginosa, Aspergillus Niger 
and Cladosporium cladosporioides, but   showed no activity against gram negative bacteria 
and fungi (Ribeiro et al., 2011). In a phytochemical study of the biological chemical 
constituents of Platanus orientalis and Platanus acerifolia buds for its use as an estrogen and 
antiestrogen like activities, this compound was isolated in a very small amount and tested 
inactive for the purposed activity (Dang et al., 2016).  A butyrolactone extracted from 
Moraceae plant; Ficus Carica was found to have a weak miticidal activity  (Yatagai., et al 
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1994). A short review from 2017  from journal of cardiology and cardiovascular therapy found 
that butyrolactone derived coumarins exhibited a positive cardiovascular effect mainly due to 
their antioxidant activity (Padte, Pednekar and Shejwalkar, 2017). This is the first time 3-
hydroxy 4, 4 dimethyl-4-butyrolactone has been isolated from Hypericum perforatum.  
 
Gilani et al (2005; 2011) reported a combination of vasoconstrictor and vasodilatatory effects 
with different extracts of Hypericum perforatum in isolated aorta preparations, and a cardio-
suppressant effect similar to that of papaverine at concentration 20 times higher than those 
required to produce spasmolytic effect in smooth muscle preparations when tested on isolated 
guinea-pig atria (Gilani et al., 2005; Khan, Gilani and Najeeb-Ur-Rehman, 2011). This is the 
first report of ACEI effect from either an extract or a compound isolated from Hypericum 
perforatum.  The ACEI effect of 3-hydroxy 4, 4 dimethyl-4-butyrolactone have never been 
studied or documented. 3-hydroxy 4, 4 dimethyl-4-butyrolactone was less active than captopril 
in inhibiting the actions of ACE (IC50 of 63.88 µg/ml, compared to 0.0165 ug/ml), it however 
is comparable to the ACE inhibitory activity reported with various compounds including 
Delphinidin-3-O-sambubioside, Quercetin glucuronide ,cyanidin-3-O- sambubioside, 
Luteolin-7-O-glucopyranoside, Epicatechin - tetramer and  various plant extracts including 
Hibiscus sabdariffa, Camelia synensis, Vaccinium ashei reade, Senecio inaequidens, S. 
ambiguous subsp. Ambigus ,S. ambiguous subsp. Ambigus, Cryptomeria japonica, and Malus 
domestica (Balasuriya and Rupasinghe, 2011). Although 3-hydroxy 4, 4 dimethyl-4-
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butyrolactone was less active than captopril in inhibiting the actions of ACE, it was shown to 
possess a significant ACEI activity and has potential as a lead compound for the synthesis of 
more active ACEIs.  
The structure of the isolated compound is dissimilar to that of compounds previously reported 
as inhibitors of ACE like flavonoids, flavanol, flavones, isoflavones and anthocyanin. It has 
been suggested that the inhibition of ACE activity identified with  these secondary  metabolites 
maybe due to their rigid structure and presence of hydroxylated aromatic ring.(Bonesi et al., 
2010). Although 3-hydroxy 4, 4 dimethyl-4-butyrolactone has a structure that is much simpler 
than these compounds, the presence of a hydroxy (-OH) group attached to position 3 of the 
identified structure might have contributed greatly to ACE inhibitory effect of 3-hydroxy 4, 4 
dimethyl-4-butyrolactone. 
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CHAPTER 5 
CONCLUSION 
 
A compound - 3-hydroxy 4, 4 dimethyl-4-butyrolactone was isolated from the ethanol extracts 
of the powdered stem and leaves of Hypericum perforatum using ACEI assay-guided 
fractionation techniques. The chemical formula as well as the structure of the compound was 
determined using NMR, MS and IR techniques. In this study, the isolated compound, 3-
hydroxy 4, 4 dimethyl-4-butyrolactone was found to possess significant ACE inhibition 
activity which was compared to that of standard drug captopril (control).  
This is the first report of 3-hydroxy 4, 4 dimethyl-4-butyrolactone being isolated Hypericum 
perforatum and also the first report of its ACE inhibitory effect. Although 3-hydroxy 4, 4 
dimethyl-4-butyrolactone showed ACE inhibitory effect less than that of captopril, has 
potential as a lead compound for the synthesis of more active ACEIs for the treatment of 
hypertension. 
 
Further studies especially, in vivo experiments are however needed to fully characterise the 
antihypertensive effect of 3-hydroxy 4, 4 dimethyl-4-butyrolactone isolated from Hypericum 
perforatum.  
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Limitations  
 
The ACE in vitro bioassay was the only approach used to access inhibitory effect of Hypericum 
perforatum extracts and due to time constraints, and the lack of access to animals, in vivo assays 
could not be conducted to confirm this activity.  
 
 
. 
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APPENDICES 
 
APPENDIX I : 1H SPECTRA OF 3-HYDROXY 4, 4 DIMETHYL-4-
BUTYROLACTONE 
Figure A1.  1H NMR spectrum (400 MHz, CDCl3) of 3-hydroxy 4, 4 dimethyl-4-butyrolactone 
 
 
 
 
 
 
 
http://etd.uwc.ac.za/
83 
 
APPENDIX II HSQC SPECTRUM FOR 3-HYDROXY 4, 4 DIMETHYL-4-
BUTYROLACTONE 
Figure A2.  HSQC spectrum of 3-hydroxy 4, 4 dimethyl-4-butyrolactone 
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APPENDIX III HMBC SPECTRUM FOR 3-HYDROXYL 4, 4 DIMETHYL-4-
BUTYROLACTONE 
 
 
Figure A3.  HMBC spectrum of 3-hydroxy 4, 4 dimethyl-4-butyrolactone 
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APPENDIX IV :FTIR SPECTRUM FOR 3-HYDROXY 4, 4 DIMETHYL-4-
BUTYROLACTONE  (TRIPLCATE ) 
 
Figure A4: FTIR spectrum for 3-hydroxy 4, 4 dimethyl-4-butyrolactone acquired thrice  
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APPENDIX V :GC-MS SPECTRA FOR 3-HYDROXY 4, 4 DIMETHYL-4-
BUTYROLACTONE 
Figure A5: GC-MS spectra for 3-hydroxy 4, 4 dimethyl-4-butyrolactone  
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APPENDIX VI : CERTIFICATE OF ANALYSIS OF HYPERICUM PEFORATUM  
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